{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T07:40:43Z","timestamp":1685000443842},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.transproceed.2009.03.034","type":"journal-article","created":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T09:16:52Z","timestamp":1242811012000},"page":"1195-1200","source":"Crossref","is-referenced-by-count":0,"title":["Adacolumn Treatment in Kidney Transplant Patients With Hepatitis C Virus"],"prefix":"10.1016","volume":"41","author":[{"given":"G.","family":"Novelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Poli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pretagostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ruberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Nudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.B.","family":"Berloco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2009.03.034_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.transproceed.2009.03.034_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0272-6386(03)00828-X","article-title":"Hepatitis C and renal disease: an update","volume":"42","author":"Meyers","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2009.03.034_bib3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.ajkd.2004.12.014","article-title":"Hepatitis C infection is acquired pre-ESRD","volume":"45","author":"Bergman","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2009.03.034_bib4","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2009.03.034_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.ajkd.2006.07.004","article-title":"Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region","volume":"48","author":"Di Napoli","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2009.03.034_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-2036.2004.02290.x","article-title":"Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis","volume":"20","author":"Fabrizi","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2009.03.034_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ki.1997.139","article-title":"Hepatitis C virus infection in dialysis and renal transplantation","volume":"51","author":"Pereira","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2009.03.034_bib8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/00007890-199811150-00023","article-title":"Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy","volume":"66","author":"Toth","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.03.034_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cyto.2007.05.013","article-title":"Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics","volume":"39","author":"Wald","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.transproceed.2009.03.034_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/lt.500050417","article-title":"Fibrosing cholestatic hepatitis in Renal transplant recipients with hepatitis C virus infection","volume":"5","author":"Delladetsima","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.transproceed.2009.03.034_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes","volume":"29","author":"Prieto","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2009.03.034_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2003.12.015","article-title":"Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination","volume":"40","author":"Dumortier","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00007890-199409150-00018","article-title":"Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients","volume":"58","author":"Thervet","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.03.034_bib14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection","volume":"59","author":"Magnone","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.03.034_bib15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.03.034_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts","volume":"1","author":"Cruzado","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.03.034_bib17","first-page":"356","article-title":"Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites for the virus","volume":"85","author":"Cravatto","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2009.03.034_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jmv.1095","article-title":"Study of the infection of human blood derived monocyte\/macrophage with hepatitis C virus in vitro","volume":"65","author":"Caussin-Scwemling","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/infdis\/166.6.1276","article-title":"Hepatitis C is detected in a monocyte macrophage subpopulation of peripheral blood mononuclear cells of infected patients","volume":"166","author":"Bouffard","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transproceed.2009.03.034_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transproceed.2009.03.034_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transproceed.2009.03.034_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1381612033391928","article-title":"Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column","volume":"9","author":"Sawada","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.transproceed.2009.03.034_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1525-1594.1997.tb00513.x","article-title":"Granulocytapheresis in the treatment of patients with rheumatoid arthritis","volume":"21","author":"Ohara","year":"1997","journal-title":"Artif Organs"},{"key":"10.1016\/j.transproceed.2009.03.034_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.dld.2005.01.014","article-title":"Selective granulocyte and monocyte apheresis as a new adjunct to enhance the efficacy of interferon-alpha + ribavirin in patients with high plasma hepatitis C virus","volume":"37","author":"Sawada","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.transproceed.2009.03.034_bib25","first-page":"228","article-title":"A new treatment for HCV-ulcerative colitis co-morbidity intolerant to IFN-alpha","volume":"98","author":"Sawada","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1774-9987.2005.00229.x","article-title":"Suppression of inflammatory cytokines secretion by granulocyte\/monocytes adsorptive apheresis in active ulcerative colitis","volume":"2","author":"Andoh","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transproceed.2009.03.034_bib27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1572-0241.2004.30432.x","article-title":"Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis","volume":"99","author":"Hanai","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib28","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3748\/wjg.v12.i21.3393","article-title":"Effects of Adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with ulcerative colitis","volume":"12","author":"Hanai","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","article-title":"Selective neutrophil and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study","volume":"49","author":"Suzuki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2009.03.034_bib30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Solubile tumour necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoximia and functionsimultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.20046","article-title":"Adacolumn for selective leukocytapheresis as a nonpharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?","volume":"20","author":"Saniabadi","year":"2005","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transproceed.2009.03.034_bib32","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","article-title":"The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF","volume":"168","author":"Belge","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5414\/CPP41459","article-title":"Proinflammatory blood monocytes: main effector and target cells in systemic and renal disease; background and therapeutic implications","volume":"41","author":"Scherberich","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2009.03.034_bib34","first-page":"170","article-title":"A disquisition on suppressor T cells","volume":"26","author":"Gershon","year":"1975","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2009.03.034_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.transproceed.2009.03.034_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0952-7915(99)00007-2","article-title":"What is the role of regulatory T cells in transplantation?","volume":"11","author":"Sakaguchi","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.transproceed.2009.03.034_bib37","first-page":"1151","article-title":"Immunologic tolerance maintained by activade T cells expressing 11.2 receptor-chains(CD25)","volume":"155","author":"Zhai","year":"1995","journal-title":"J Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509004217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509004217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T07:27:53Z","timestamp":1684999673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134509004217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0041134509004217"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2009.03.034","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}